Beijing Zhidemai Technology (300785.SZ) stock: key figures, P/E, revenue and dividend
Communication Services · Interactive Media & Services · China · ISIN CNE100003LV2
Beijing Zhidemai Technology financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.52 bn CNY | 1.29 bn CNY |
| Gross profit | 716.23 m CNY | 646.06 m CNY |
| Operating income | 82.94 m CNY | 92.82 m CNY |
| EBIT | 69.94 m CNY | 92.77 m CNY |
| Net income | 75.24 m CNY | 86.52 m CNY |
| Diluted EPS – continuing operations | 0.38 CNY | 0.44 CNY |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Beijing Zhidemai Technology
Beijing Zhidemai Technology Co., Ltd. engages in the Internet marketing and data service-related businesses in China and internationally. It involved in Internet information promotion activities. The company also provides consumer content, and content creation services. Beijing Zhidemai Technology Co., Ltd. was founded in 2011 and is headquartered in Beijing, China.
More stocks
- TRUSTCO BANK CORP N Y (TRST)
- Suzhou Sushi Testing Instrument Co Ltd (300416.SZ)
- Ganzhou Yihao New Materials Co. Ltd. A (301176.SZ)
- Lihuayi Weiyuan Chemical Co Ltd (600955.SS)
- AdaptHealth Corp. (AHCO)
- WINMARK CORP (WINA)
- Dazzle Fashion Co Ltd (603587.SS)
- Rastar Environmental Protection Materials Co.Ltd. (300834.SZ)
- Sats ASA (SATS.OL)
- Polar Capital Holdings PLC (POLR.L)
- Sabine Royalty Trust (SBR)
- MoonLake Immunotherapeutics (MLTX)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.